PEPG · PepGen Inc. · Executive Compensation
$2.53
-0.07 (-2.69%)
At close · Oct 28
Return incl. dividend (before tax)
Q4 2023 earnings call transcript
Market Cap
$180.07M
Shares
69.26M
Volume · Oct 28
767.8K
Avg daily vol (3M)
934.42K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $3,316,783 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,758,882 |
| Joseph D. Vittiglio | J.D., Chief Business and Legal Officer | $1,319,816 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $4,426,218 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $2,349,969 |
| Paul Streck | M.D., M.B.A. Executive Vice President, Head of Research & Development | $2,072,267 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $3,425,703 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,973,551 |
| Michelle Mellion | Senior Vice President, Clinical Development | $1,411,171 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $4,511,477 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,983,872 |
| Niels Svenstrup | Senior Vice President, Chemistry, Manufacturing and Controls | $1,322,057 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James McArthur | President and Chief Executive Officer | $4,088,874 |
| Noel Donnelly | M.B.A. Chief Financial Officer | $1,775,211 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lisa Wyman | Class I director | Appointed | 2025-03-31 |
| Mitchell Finer, Ph.D. | Class III director | Appointed | 2025-03-31 |
| Michelle L. Mellion, MD | Chief Medical Officer | Resigned | 2025-03-28 |
| Habib J. Dable | member of the Board's Audit Committee | Appointed | 2024-09-19 |
| Christopher Ashton, Ph.D. | Board of Directors | Resigned | 2024-09-19 |
| Habib J. Dable | director | Appointed | 2022-09-22 |
Leadership
- Noel Donnelly CFO
- Mary Beth DeLena General Counsel
- Habib J. Dable Board Member
- Howard Mayer Board Member
- Joshua Resnick Board Member
- Lisa Wyman Board Member
- Mitchell Finer, Ph.D. Board Member